Editorial
Is chest radiation now a classical practice for extensive small cell lung cancer?
Translational Lung Cancer Research
2015;
4
(3)
:209-210
.
(24 June 2015)
Consolidative radiation therapy for extensive-stage small cell lung cancer
Translational Lung Cancer Research
2015;
4
(3)
:211-214
.
(24 June 2015)
First-line nivolumab (anti-PD-1) monotherapy in advanced NSCLC: the story of immune checkpoint inhibitors and “the sorcerers apprentice”
Translational Lung Cancer Research
2015;
4
(3)
:215-216
.
(24 June 2015)
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harboring EGFR mutations (JO25567): an open-label, randomized, multicenter, phase II study
Translational Lung Cancer Research
2015;
4
(3)
:217-219
.
(24 June 2015)
Anatomic segmentectomy for non-small cell lung cancer: can we believe the hype?
Translational Lung Cancer Research
2015;
4
(3)
:220-222
.
(24 June 2015)
Improved overall survival following tyrosine kinase inhibitor treatment in advanced or metastatic non-small-cell lung cancer— the Holy Grail in cancer treatment?
Translational Lung Cancer Research
2015;
4
(3)
:223-227
.
(24 June 2015)
Original Article
18F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy
Translational Lung Cancer Research
2015;
4
(3)
:228-235
.
(24 June 2015)
Prognostic value of Twist in lung cancer: systematic review and meta-analysis
Translational Lung Cancer Research
2015;
4
(3)
:236-241
.
(24 June 2015)
Review Article
Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance
Translational Lung Cancer Research
2015;
4
(3)
:242-252
.
(24 June 2015)
The past, present and future of immunotherapy against tumor
Translational Lung Cancer Research
2015;
4
(3)
:253-264
.
(24 June 2015)
The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer
Translational Lung Cancer Research
2015;
4
(3)
:265-274
.
(24 June 2015)
Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals
Translational Lung Cancer Research
2015;
4
(3)
:275-286
.
(24 June 2015)
Mini-Review
Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells
Translational Lung Cancer Research
2015;
4
(3)
:287-291
.
(24 June 2015)
Letter to the Editor
Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?
Translational Lung Cancer Research
2015;
4
(3)
:292-294
.
(24 June 2015)
Meet the Professor1
Professor Robert Pirker: primary prevention and early detection of lung cancer should be strengthened
Translational Lung Cancer Research
2015;
4
(3)
:295-297
.
(24 June 2015)
Professor Helmut H. Popper: the major challenges and potential solutions for future management of lung cancer
Translational Lung Cancer Research
2015;
4
(3)
:298-299
.
(24 June 2015)
Evidence-Based Medicine2
Clinicopathologic characteristics of patients with ROS1 fusion gene in non-small cell lung cancer: a meta-analysis
Translational Lung Cancer Research
2015;
4
(3)
:300-309
.
(24 June 2015)
Expert Consensus
Expert consensus on image-guided radiofrequency ablation of pulmonary tumors—2015 edition
Translational Lung Cancer Research
2015;
4
(3)
:310-321
.
(24 June 2015)
Disclosure:
1. The series “Meet the Professor” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
2. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
